Post-cycle: No harsh rebound
Customer Focus: Your comfort and satisfaction are our top priorities
When BPC-157 and related compounds are formally returned to Category 1 status, AgeMD physicians will evaluate the clinical indication on a patient-by-patient basis and prescribe accordingly
Molecules , 2020 Unlike many peptides, BPC-157 exhibits systemic effects even when injected locally , making it uniquely versatilebut also requiring careful consideration of delivery method and dosage
Laboratory studies investigate effects on fibroblast cultures and extracellular matrix synthesis pathways
Brain and Cognitive Health BPC-157 is evidenced to have neuroprotective properties, attenuating damage due to strokes and central nervous system injuries while balancing neurotransmitters to combat symptoms of depression, Parkinsons disease, and schizophrenia [2, 11, 34]